TransMedics Group, Inc. TMDX

Latest FY: 2025 Healthcare Medical Devices
Market Price $85.10
Market Cap $2.94B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑37.1% YoY
$605.49M
3-Yr CAGR: 86.4%
Net Income ↑436.6% YoY
$190.29M
Net Margin: 31.4%
Free Cash Flow ↑265.0% YoY
$133.59M
FCF Yield: 4.54%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
40.2%
ROA: 17.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TMDX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $14.7M $5.7M $-23.8M $-26.0M $-26.4M
FY 2019 $25.8M +76.3% $13.9M $-33.5M -41.2% 0.00% $-32.3M $-32.5M -22.9%
FY 2020 $25.6M -0.8% $16.6M $-28.7M +14.3% 0.00% $-30.3M $-30.7M +5.3%
FY 2021 $30.3M +18.0% $21.2M $-44.2M -53.8% 0.00% $-28.9M $-32.4M -5.4%
FY 2022 $93.5M +208.8% $65.3M $-36.2M +18.1% 0.00% $-45.8M $-57.7M -78.3%
FY 2023 $241.6M +158.5% $154.1M $-25.0M +30.9% 0.00% $-13.0M $-164.9M -185.6%
FY 2024 $441.5M +82.7% $262.1M $35.5M +241.7% 0.00% $48.8M $-80.9M +50.9%
FY 2025 $605.5M +37.1% $362.8M $190.3M +436.6% 0.00% $192.8M $133.6M +265.0%
$

Valuation

Market Price $85.10
Market Cap $2.94B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 6.22
FCF Yield 4.54%
Dividend Yield N/A
Shares Outstanding 34,560,900
%

Profitability & Margins

Gross Margin 59.92%
Operating Margin 17.93%
Net Margin 31.43%
Return on Equity (ROE) 40.22%
Return on Assets (ROA) 17.81%
Asset Turnover 0.57x
Revenue 3-Yr CAGR 86.42%
🛡️

Financial Health & Liquidity

Current Ratio 0.26
Cash Ratio N/A
Debt / Equity 1.083
Debt / Assets 0.480
Cash & Equivalents N/A
Total Debt $512.39M
Book Value / Share $13.69
💧

Cash Flow Efficiency

Operating Cash Flow $192.84M
Capital Expenditures (CapEx) $59.25M
Free Cash Flow $133.59M
OCF / Revenue 31.85%
FCF / Revenue 22.06%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $13.69
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.07B
Total Liabilities $595.27M
Stockholders' Equity $473.10M
Current Assets $16.25M
Current Liabilities $62.74M